Genetic variability has been implicated as a significant contributor to the variation in levels of lipids, lipoproteins, and apolipoproteins (apos) through a variety of direct and indirect investigations. Among the direct investigations, apo E has been shown to be polymorphic and to explain a small but statistically significant proportion of the variability in cholesterol. The apo E polymorphism was typed in 964 randomly selected Mexican-Americans from StanCounty, Tex., and its effects determined on levels of cholesterol, triglycerides, total high density lipoprotein (HDL) cholesterol, subtractions (HDL? and HDL,), at-and ^-lipoprotein cholesterol, low density lipoprotein (LDL) cholesterol, and apos A-I, A-II, B, C-II, C-III, and E. Effects are reported for the entire sample and in each of three groups, namely, premenopausal females, postmenopausal women, and males. In the entire sample, significant effects were observed on cholesterol, ^-lipoprotein cholesterol, LDL, apo B, and apo E. There is evidence for significant physiological interaction of the apo E polymorphism effect in females by menopausal status. This is most evident for apo E levels, in which 5.9% of the variability in the entire sample is explained by the apo E polymorphism. In premenopausal females, however, the polymorphism accounts for 27.5% of the variability. In postmenopausal women and males, there is no significant effect It is shown that the apo E polymorphism can be treated as a two-locus, two-allele system. Doing so identifies substitutions in amino acid position 158 as the mediators of most of the observed effects of this polymorphism. [Arteriosclerosis and Thrombosis 1991;ll:362-370) O f the many factors affecting cardiovascular disease risk, cholesterol is one of the best understood. With this understanding has come the technology for measuring cholesterol content in the various lipoprotein particles involved in cholesterol metabolism and the concentrations of many of the associated apolipoproteins (apos). lipid-related measures rather than simple cholesterol levels. Levels of lipids, lipoproteins, and apos vary markedly from individual to individual, and several studies have shown that a significant proportion of this variability is attributable to inferred genetic differences among individuals. 3 -6 Direct studies of genetic variation at loci known to be important in lipid metabolism have revealed how simply inherited variation can contribute to the differences in levels among individuals. The apo E polymorphism 7 ' 8 is among the best studied, and it explains a consistently significant albeit small proportion of the variability in cholesterol levels.
O f the many factors affecting cardiovascular disease risk, cholesterol is one of the best understood. With this understanding has come the technology for measuring cholesterol content in the various lipoprotein particles involved in cholesterol metabolism and the concentrations of many of the associated apolipoproteins (apos).
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These additional measures have led to refinements in the risk classification that account for the profile of levels. 10 Apo E serves as a ligand in receptor-mediated uptake of lipoproteins. Furthermore, the various isoforms differ with regard to their efficiency of receptor binding and distribution among lipoproteins. 15 - 18 These observations of metabolism lead to straightforward mechanisms that likely underlie the consistent statistical effects of the apo E polymorphism on lipid-related measures. 1013 The chronic disease pattern among MexicanAmericans in Texas and elsewhere is dominated by high frequencies of non-insulin-dependent diabetes mellitus, obesity, and gallbladder disease, but there does not seem to be a corresponding increase in cardiovascular disease. 19 " 24 We have undertaken detailed physical and laboratory evaluations on 1,004 randomly selected Mexican-American residents of Starr County, Tex. Chronic disease frequencies are considerably elevated in this population, but lipid, lipoprotein, and apo levels do not demonstrate a general tendency for untoward profiles. 21 In this article, we examine the effects of the apo E polymorphism on levels of these lipid-related factors.
The molecular basis of the common apo E protein polymorphism involves substitutions in amino acids 112 and 158. 25 - 26 The E3 isoform has amino acids cysteine and arginine at positions 112 and 158, respectively. E4 has arginine at both positions. The E2 isoform has cysteine at both sites and has been shown to have reduced receptor-binding affinity: only 1% of that observed for the E3 allele. 15 Because each substitution involves an amino acid-charge change, electrophoretic differences among the three protein isoforms represent haplotype differences at the DNA level. Therefore, the apo E polymorphism can be treated as a one-locus, three-allele system or as a two-locus, two-allele system. As has been done previously, we report results in terms of one locus with three alleles. However, by examining positions 112 and 158 as separate loci, it is possible to explicitly test the effects of amino acid substitutions at each site. We demonstrate that such an approach is unaffected by the disequilibrium between these physically close sites and provide evidence for a significant interaction between amino acid substitutions at position 158 and menopausal status in women.
Methods

Subjects
The population and sampling characteristics have been detailed elsewhere, 21 and we only briefly review the protocols here. Within Starr County, Tex., blocks were randomly selected from the three major towns. On selected blocks, all dwelling units were enumerated, and one individual between the ages of 15 and 74 years, inclusively, was randomly selected from each unit for a detailed physical examination. Examinations were performed approximately one weekend per month in our field office in Rio Grande City, Tex., from April 1985 to November 1986. At the examination, fasting blood samples were collected by venipuncture into EDTA-containing Vacutainer tubes (Venoject, Terumo Medical, Elkton, Md.; Becton Dickinson, Oxnard, Calif.)
Lipid, Lipoprotein, and Apolipoprotein Determinations
Within 5 days of collection, cholesterol (Choi), triglycerides (Trig), total high density lipoprotein (HDL) Choi, and HDL subfractions 2 and 3 (HDLz and HDL 3 ) were determined using standard protocols and dextran sulfate/Mg 2+ precipitation. 27 a-and /3-lipoprotein fractions were obtained using heparinaffinity chromatography columns 28 (Isolab, LDLDirect, Akron, Ohio). LDL levels were calculated as total Choi less HDL less very low density lipoprotein (VLDL), where VLDL was estimated as one fifth of total Trig. 29 These determinations were made on all individuals.
Subsequent to the start of the examinations, further funding was obtained, thereby permitting measurement of apo levels. These were begun in April 1986. Apo A-I levels were determined by radioimmunoassay (Ventrex, Portland, Me.) on frozen samples. The other apos were measured from nonfrozen samples within 5 days of collection. Rocket immunoelectrophoresis 30 was used to measure apo B levels (antisera from Boehringer Mannheim, Mannheim, F.R.G.), whereas levels of apos A-II, C-II, C-III, and E were determined by radial immunodiffusion 31 (Daiichi Pure Chemical, Tokyo, Japan). In addition to analyzing all samples starting in April 1986, we resampled 100 women aged 35 to 55 years who were examined before this time to obtain fresh samples for analysis. A variety of quality control procedures were implemented, including participation in the International Union of Immunological Societies-National Heart, Lung, and Blood Institute-Centers for Disease Control Collaborative Apolipoprotein Standardization Program for apos A-I and B and routine duplicate analysis of lipids and lipoproteins on 10% of our samples at the Baylor College of Medicine Atherosclerosis Clinical Laboratory.
The three major protein isoforms of apo E (E2, E3, E4) were detected using an agarose isoelectric focusing-immunoblotting micromethod requiring delipidation and desialylation but not ultracentrifugation 14 (antisera from Daiichi Pure Chemical). The three isoforms give rise to six distinguishable phenotypic classes that can be interpreted in the conventional manner as due to one locus with three alleles or as the product of two loci (sites). As a two-locus system, we name the "loci" E 112 and E 15g , corresponding to the amino acid positions involved in the substitutions. At each locus, there are two alleles, C and R, representing whether the amino acid at each is cysteine (C) or arginine (R). Individuals of E 112 genotype CC correspond to individuals with isoform types E2E2, E2E3, or E3E3. E 112 CR corresponds to E2E4 or E3E4, whereas E 112 RR is equivalent to E4E4. For E 158 , the matching type for CC is E2E2; CR is represented by E2E3 and E2E4; and RR includes E3E3, E3E4, and E4E4.
Statistical Methods
Allele frequencies were estimated by maximumlikelihood methods and tested for goodness of fit to Hardy-Weinberg equilibrium using x 1 statistics. To assess the effect of the polymorphic variability on quantitative levels, analysis of covariance techniques were employed. 32 Age and age squared were included as covariates. Preliminary analysis indicated that there were significant effects due to sex and menopausal status on several of the lipid-related measures. It has also been recently reported that the relations of lipids to concomitants such as age are apo E-type dependent. 33 Consequently, we employed a strategy of repeating all analyses of covariance in each of three strata, namely, premenopausal females, postmenopausal women, and all males. Menopausal status was based on interview. The significance of apo E polymorphism effects was assessed using the F ratio test for equality of means. The proportion of variability explained by the polymorphism (i.e., the R 2 ) was taken to be a measure of the impact of the effect. The R 2 was calculated as the sum of squares due to the polymorphism divided by the covariate-adjusted total sum of squares (sum of squares total less the covariate sum of squares). The analyses were first performed assuming a one-locus, three-allele system, and then substitutions at each amino acid site were considered separately. Because of the number of variables analyzed and the multiple treatments, there exists the possibility of obtaining spurious results due to chance alone. Recent work suggests that adjustment for multiple testing may not be necessary 34 ; however, to aid interpretation of the magnitude of effects, we have provided p values for all statistical tests rather than simply categorizations of significance levels.
Treating apo E as a two-locus system with loci in such close physical proximity leads to obvious concerns regarding the extent of disequilibrium between E 112 and E 158 . To evaluate their independence, contingency x 2 analysis of the two-locus genotypes was undertaken. The disequilibrium coefficient between E 112 and E 158 was also computed and tested for departure from zero. 35 To calculate the disequilibrium coefficient, unequivocal classification of haplotypes is required. This is only possible from the electrophoretic data, assuming that no haplotypes with arginine at 112 and cysteine at 158 are present (electrophoretically equivalent to the e3 allele). That this assumption is reasonable is based on the lack of reports of this haplotype. Furthermore, in other studies, we have typed a supplementary group of approximately 500 Mexican-Americans from the same population using DNA amplification via the polymerase chain reaction and restriction with Hha I, which allows unequivocal classification of types. 36 In no case has this hypothetical argmine 112 cysteine 1 5 8 haplotype been observed (C.L. Hanis, unpublished observations). Given the disequilibrium value between the two loci, we 37 have shown elsewhere that the magnitude of the effect of one locus on a quantitative trait due to disequilibrium with a second locus that affects that trait is the product of the R 2 value associated with the second locus and the squared correlational measure of disequilibrium. This result is dependent on allele and haplotype frequencies and is valid for arbitrary interlocus distances. We use this product to partition the proportion of explained variability into two components, namely, that due to disequilibrium and that due to the effect of the locus itself. For example, we calculate the magnitude of the effect of variability at E 112 on apo E levels that is attributable to disequilibrium with E 158 .
Results
Apo E typing was completed on 964 individuals.
No blood samples were obtained from seven individuals, nor were determinations done on an additional 33 samples (these represent samples collected in the first month that were not analyzed). Of the 964 typed, 963 fell into the six common phenotypic classes expected. One individual had a variant type and has been excluded from the analyses here. The phenotypic counts and expectations under Hardy-Weinberg equilibrium are provided in Table 1 for both the one-locus and two-locus treatments. There is no evidence for departure from Hardy-Weinberg expectations under either model. Under the traditional model, the six phenotypic groupings give allele frequency estimates (SEMs) of 0.039 (0.004), 0.859 (0.008), and 0.102 (0.007) for the e2, e3, and et alleles, respectively. As in other populations, the e3 allele is the most common (0.859) and is among the highest that have been observed. 13 Under the two- locus system, the frequency of E m C is 0.898 (0.007), and the frequency of R is 0.102 (0.007). At position 158, the frequencies of C and R are 0.039 (0.004) and 0.961 (0.004), respectively. In Table 2 , the adjusted mean levels and SEMs for the lipids and Hpoproteins (Choi, Trig, a-and /3-lipoprotein fractions, HDL, HDL,, HDLj, and LDL) arrayed by apo E isoform phenotypes are presented. The table is organized in four sections; in the first, data for all subjects are summarized, and then the data are separated into premenopausal females, postmenopausal women, and all males. Within each section, the proportion of variability explained by the apo E polymorphism (R 2 ) is given, as well as the probability that the mean level differences among apo E types are due to chance alone. For example, consider the Choi column in the section relating to "All subjects." The mean Choi level (adjusted to the mean age) for the population is 197 mg/dl. As in other studies, mean Choi in E2E3 individuals is lower (177 mg/dl), while being slightly higher for E3E4 individuals (202 mg/dl). Overall, the differences among mean Choi levels in the different apo E groups are significant at the 0.001 level (p=0.000). These differences among groups explain 2.4% of the variability in Choi in this Mexican-American population. Significant differences among levels were also observed for /3-lipoprotein Choi and LDL, in which the apo E polymorphism explained 3.2% and 2.9% of the variability, respectively. Concerning the three subgroups, it is seen that the general trends are similar to those for all subjects; however, they seem to be more moderate in the two female groups. This is evidenced by the lack of significance in all but LDL levels in premenopausal females. Findings in males parallel those for the total sample. Note that within each subgroup, mean levels have been adjusted to represent the mean age for that subgroup. As a consequence, the values for all subjects are not simply the weighted averages from the subgroups. Table 3 in the same fashion as in Table 2 . In the "All subjects" grouping, the apo E polymorphism has significant effects on apo B and apo E levels, explaining 3% and 5.9% of the variability in each, respectively. These results are similar to those previously reported, 10 
Results for apos A-I, A-D, B, C-II, C-III, and E are presented in
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14 except that the effect on apo E levels is substantially smaller. There were no significant effects on levels of apos A-I, A-II, C-II, or C-III. We are not aware of comparative data in the literature for these latter apos as they relate to the apo E polymorphism. Examining the two female classifications and males separately, a different picture emerges than when the entire group is the focus. The effect of the apo E polymorphism on apo E levels is only significant in premenopausal females, in whom it explains 27.5% of the variability in apo E levels. Individuals bearing an e2 allele have consistently higher mean apo E levels than the sample mean, while those with an e4 allele have lower levels. The observed significant effect in only the premenopausal female group is compatible with an interaction between apo E type and physiological status that is likely mediated by hormonal factors (see "Discussion").
While apo E levels are significantly different among apo E types in premenopausal females (p=0.000), there are no such differences in apo B levels in this group. In males and postmenopausal women, the apo E polymorphism has a consistent and significant effect on apo B levels and explains about 6% of the variability in each group. In males, there is also a highly statistically significant effect of the apo E polymorphism on apo C-II levels (p=0.001), in whom it explains 13.7% of the variation in apo C-II concentrations. Other reports in the literature have not separated the data into sex and menopause groups and therefore do not permit comparison of these latter results.
Of all the relations in Tables 2 and 3 , the strongest effects of the apo E polymorphism are on plasma apo E levels. To establish to which of the two amino acid sites this variation was attributable, the data were reanalyzed based on E 112 and E^g phenotypes. The results of these analyses on apo E levels are summarized in Figure 1 . Mean apo E levels among E 112 phenotypes are statistically significant only in the premenopausal female group (/>=0.018) in whom they explain 3.1% of the variability in apo E levels. E^g differences are also significant in premenopausal females (p=0.000) and explain 23.9% of the variability in levels. Thus, the large effect observed in Table 3 is shown to be primarily a function of amino acid substitutions at position 158. It should be noted that in Figure 1 , inclusion of the one E 158 CC individual in the premenopausal female group (apo E of 8.4 mg/dl) is not required for statistical significance; indeed, the results are equivalent with or without this individual. E 1M also has significant effects on apo E levels in postmenopausal women (/?=0.021, #=3.4%), but the effect was much smaller than that in premenopausal females. E 158 had no significant effect on apo E levels in males.
Repeating the analyses by E u2 and E 15g for the other lipid-related measures further confirms that substitutions at position 158 have the greater effect. The only other significant E 112 effect was on HDL levels in premenopausal females (p = 0.037, #=1.6%). E 158 had statistically significant effects on Choi, LDL, and apo B levels in postmenopausal women and males but not in premenopausal females. In no case did the proportion of explained variability exceed 5.3%. There was also a significant effect on the 0-lipoprotein fraction in males (p=0.001, #=5.1%).
To assess the independence of E 112 and E 15g , the frequencies of the two-locus phenotypes were compared with their Hardy-Weinberg expectations. The departures between observed and expected counts were not statistically significant. The maximum-likelihood estimate of the disequilibrium coefficient between E 112 and E U8 was 0.004, which is statistically significant from zero (^-2 =9.0, one degree of freedom). The absolute magnitude of the disequilibrium is small because of the low frequencies of alleles E 112 R and E 158 C. Even though the disequilibrium is low, it is the maximal value that could be observed due to the absence of the argininen^steine^ haplotype. The correlational measure of disequilibrium was 0.068 and leads to the prediction that in premenopausal females, E 112 should explain 0.1% (0.068 x 0.068x23.9%) of the variability in E levels due to disequilibrium with E 1S8 , which shows such a large effect. This is negligible, and, as a result, E 112 and E 15g can be treated as independent in practice even though they are encoded by the same exon and are only 46 amino acids apart. Values are mean and (SEM). the uncommon alleles higher, then the loci would not have behaved as though independent.
Discussion
The results presented have several implications for analysis and, more importantly, for the possibility of significant interaction between physiological status and genotype. First, where frequencies of alleles are in the range of those presented here, it is possible to consider physically linked loci as functionally independent. Consequently, the strategy of examining each site separately may have merit in identifying the particular site that is phenotypically important. In the present case, this strategy confirmed what was known from metabolic studies, namely, that amino acid substitutions at position 158 have the greater impact. 15 In studies of associations between genotypic variability and quantitative levels of phenotypes, it is often argued that the effect observed is not due to the genotype being studied; rather, it is due to disequilibrium with a closely linked marker that has the effect. 38 The present example clearly indicates the dependence of the argument invoking disequilibrium on allele frequencies.
The mechanism by which E 15g affects apo E levels has not been completely elucidated, but it is probably a function of the differential binding of the isoforms to the apo B/E receptor and subsequent accumulation of apo E-containing lipoproteins. 10 What is not understood, however, is the mechanism that leads to such a pronounced effect in only the premenopausal female group as reported here. Furthermore, if accumulation of apo E-containing lipoproteins were the primary mechanism, then one might expect to see a similar effect in apos C-II and C-III, which overlap somewhat with apo E in their distribution in the major lipoprotein classes, 39 but this is not observed in the present data. These results require confirmation and additional study.
There are several possible explanations for the apparent interaction effect in females. One is that the differential effects of the apo E polymorphism in the three groups is a function of chance. This is not likely in the present case due to the internal consistency of effects that are observed across the groups for the lipid-related measures as a whole and the low p values obtained. Furthermore, analyzing apo E levels in a two-way analysis of covariance with apo E type and menopausal status as main effects and including an interaction term yields the same results. Also, the reported effects of the apo E polymorphism in a different population 10 is not inconsistent with our findings. In that study, the population was relatively young (mean age, 27 years) and thus, the majority of females would be premenopausal and this could account for the effect observed. A second possibility is that the interaction effect is due to a third factor that is changing in premenopausal females. We have shown elsewhere that the pattern of obesity development among Mexican-Americans is different in males and females based on age-and sex-specific prevalences. 21 We reanalyzed the data including body mass index (weight in kilograms divided by the square of height in meters) as a further covariate. Body mass index had a significant effect on apo E levels, but the effect of the apo E polymorphism remained the same. We also examined other potential explanatory covariates including fasting blood glucose, smoking, and alcohol use, and again, there were no substantial changes in the results. A third possibility is that interaction is related to physiological state, particularly hormone levels. It is becoming clear that lipoprotein changes associated with adolescence are related to sex hormones. 40 Furthermore, there is evidence that hormones are involved in the regulation of apo production 41 and regulation of receptors. 15 The LDL receptor is one such receptor whose expression is not only affected by hormones, but whose expression is age dependent. 15 Associations among hormones and lipid-related factors are also known. Estrogen administration has been shown to increase several lipoproteins in premenopausal females, 42 and sex hormone-binding globulin has been shown to be associated with increased levels of HDL, 43 also in premenopausal females. These studies have also established an interacting role of obesity and body fat distribution. These and other such observations provide plausible biologic mechanisms that may be differentially affected by apo E isoforms and may account for the strong interaction of E^g with menopausal status.
The results of this article further demonstrate the potential of simple genetic variability to explain a significant proportion of normal variability in the population. They also point to some practical considerations in light of the interaction effects observed. In the present case, the separate analyses within groups defined based on sex and menopausal status led to the identification of a significant interaction. Had the analyses not been performed within the subgroups or had inappropriate groupings been chosen, these interaction effects would likely have been masked. Finally, the consideration of apo E as a two-locus system identified the particular substitution possibly underlying the interaction.
Emphasis in this article is on the effects of the apo E polymorphism on mean levels. As is apparent as soon as one begins examining metabolic effects, it is difficult to treat each of several related measures as if it were independent of the others. It is likely that genes affect the relations among lipid variables as well. 10 As intervention strategies are proposed, it will be particularly important to understand the array of genotypic effects on levels of and relations among the various lipid-related measures in the general population and in various disease states. The identification of interactions should prove particularly valuable in this regard in that they will indicate the type of effects that can be achieved within the normal array of genetic variability.
